Philadelphia-based clinical decision support startup Oncora Medical is collaborating with University of Texas MD Anderson Cancer Center in Houston in a study to help radiation oncologists develop ...
Physicians at MD Anderson Cancer Center at Cooper are now treating patients with a groundbreaking new image-guided radiation treatment that allows oncologists to track and monitor the movement of ...
MD Anderson Cancer Center has teamed up with medtech firm RaySearch Laboratories to tackle the barriers to widespread use of adaptive radiation therapy. The partners think advanced imaging and ...
BERKELEY HEIGHTS, N.J., Nov. 29, 2017 /PRNewswire/ -- Marking a major milestone in its mission to provide world-class cancer care to patients in northern New Jersey, Summit Medical Group MD Anderson ...
HOUSTON and PHILADELPHIA ? Oncora Medical, a precision radiation oncology software company, and The University of Texas MD Anderson Cancer Center, today announced a strategic alliance focusing on ...
Histotripsy is a non-invasive treatment, approved by the Food and Drug Administration (FDA) in 2023, that uses ultrasound energy to destroy liver tumors in a single outpatient procedure. This includes ...
Houston-based University of Texas MD Anderson Cancer Center and Empyrean Medical Systems, a technology company, entered an exclusive license and joint development agreement Aug. 10. Under the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback